Cargando…

TP53-binding protein variants and breast cancer risk: a case-control study

INTRODUCTION: The TP53-binding protein (53BP1) has been shown to influence TP53-mediated transcriptional activation, thus playing a pivotal role in DNA damage signalling. Genetic aberrations in TP53 and in ATM and CHEK2 predispose to cancer. We have therefore examined the effects of 53BP1 single nuc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frank, Bernd, Hemminki, Kari, Bermejo, Justo Lorenzo, Klaes, Rüdiger, Bugert, Peter, Wappenschmidt, Barbara, Schmutzler, Rita K, Burwinkel, Barbara
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1175066/ https://www.ncbi.nlm.nih.gov/pubmed/15987456 http://dx.doi.org/10.1186/bcr1038

Ejemplares similares

The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk
por: Frank, B, et al.
Publicado: (2005)

BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study
por: Frank, Bernd, et al.
Publicado: (2007)

Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study
por: Burwinkel, Barbara, et al.
Publicado: (2006)

Association of NCOA3 (AIB1) polymorphisms with breast cancer risk
por: Burwinkel, B, et al.
Publicado: (2005)

The ‘Common Disease-Common Variant’ Hypothesis and Familial Risks
por: Hemminki, Kari, et al.
Publicado: (2008)

Nuclear receptor coregulator SNP discovery and impact on breast cancer risk
por: Hartmaier, Ryan J, et al.
Publicado: (2009)

Contribution of the Defective BRCA1, BRCA2 and CHEK2 Genes to the Familial Aggregation of Breast Cancer: a Simulation Study Based on the Swedish Family-Cancer Database
por: Bermejo, Justo Lorenzo, et al.
Publicado: (2004)

Single nucleotide polymorphisms (SNPs) are inherited from parents and they measure heritable events
por: Hemminki, Kari, et al.
Publicado: (2005)

Satisfaction and Quality of Life of Healthy and Unilateral Diseased BRCA1/2 Pathogenic Variant Carriers after Risk-Reducing Mastectomy and Reconstruction Using the BREAST-Q Questionnaire
por: Herold, Natalie, et al.
Publicado: (2022)

The updated Swedish family-cancer database used to assess familial risks of prostate cancer during rapidly increasing incidence
por: Hemminki, Kari, et al.
Publicado: (2006)

Variants at the 9p21 locus and melanoma risk
por: Maccioni, Livia, et al.
Publicado: (2013)

Socio-economic status and overall and cause-specific mortality in Sweden
por: Weires, Marianne, et al.
Publicado: (2008)

DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA
por: Tang, Qiuqiong, et al.
Publicado: (2016)

Comprehensive Identification of Deleterious TP53 Missense VUS Variants Based on Their Impact on TP53 Structural Stability
por: Tam, Benjamin, et al.
Publicado: (2021)

TP53 structural variants in metastatic prostatic carcinoma
por: Sirohi, Deepika, et al.
Publicado: (2019)

Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
por: Tesio, Melania
Publicado: (2023)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013)

TP53 variants in p53 signatures and the clonality of STICs in RRSO samples
por: Akahane, Tomoko, et al.
Publicado: (2022)

Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes
por: Hemminki, Kari, et al.
Publicado: (2010)

Molecular characterization of AML‐MRC reveals TP53 mutation as an adverse prognostic factor irrespective of MRC‐defining criteria, TP53 allelic state, or TP53 variant allele frequency
por: Zhao, Davidson, et al.
Publicado: (2022)

Common genetic variants in the TP53 pathway and their impact on cancer
por: Barnoud, Thibaut, et al.
Publicado: (2019)

Emerging insights into ethnic-specific TP53 germline variants
por: Fischer, Nicholas W, et al.
Publicado: (2023)

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
por: Langerød, A, et al.
Publicado: (2000)

TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
por: Wang, Haiwei, et al.
Publicado: (2022)

TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer
por: Fagerholm, Rainer, et al.
Publicado: (2017)

CRISPR screens are feasible in TP53 wild‐type cells
por: Brown, Kevin R, et al.
Publicado: (2019)

Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53
por: Omran, Meis, et al.
Publicado: (2020)

Influence of Genetic Variants in Type I Interferon Genes on Melanoma Survival and Therapy
por: Lenci, Romina Elizabeth, et al.
Publicado: (2012)

Somatic TP53 variants frequently confound germline testing results
por: Weitzel, Jeffrey N., et al.
Publicado: (2017)

p53/TP53 Status Assessment in Gastroesophageal Adenocarcinoma
por: Boldrin, Elisa, et al.
Publicado: (2023)

Defining TP53 pioneering capabilities with competitive nucleosome binding assays
por: Yu, Xinyang, et al.
Publicado: (2019)

Optimisation of TP53 reporters by systematic dissection of synthetic TP53 response elements
por: Trauernicht, Max, et al.
Publicado: (2023)

TP53 and MTOR crosstalk to regulate cellular senescence
por: Galluzzi, Lorenzo, et al.
Publicado: (2010)

Allelotyping of pooled DNA with 250 K SNP microarrays
por: Wilkening, Stefan, et al.
Publicado: (2007)

Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer
por: Kyndi, M, et al.
Publicado: (2005)

Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA
por: Li, Xuerui, et al.
Publicado: (2020)

The TP53 fertility network
por: Paskulin, Diego d’Avila, et al.
Publicado: (2012)

TP53: an oncogene in disguise
por: Soussi, T, et al.
Publicado: (2015)

TP53 in Myelodysplastic Syndromes
por: Jiang, Yan, et al.
Publicado: (2021)

TP53 drives invasion through expression of its Δ133p53β variant
por: Gadea, Gilles, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k1iael3nkq9r1f1n30io4fa4sd